The Ongoing Mental Health Impact of COVID-19

Jan 14, 2026, 2:39 AM
Image for article The Ongoing Mental Health Impact of COVID-19

Hover over text to view sources

The COVID-19 pandemic has had profound effects on mental health worldwide, with a reported increase in anxiety and depression by 25% during the first year of the pandemic, according to the World Health Organization (WHO). This surge in mental health issues has been attributed to various stressors, including social isolation, fear of infection, and financial uncertainties, which have disproportionately affected young people and women.
As we navigate the aftermath of the pandemic, the concept of long COVID has emerged as a significant concern. Long COVID refers to a range of symptoms that persist for weeks or months after the initial COVID-19 infection, affecting approximately 5% to 10% of those infected, regardless of the severity of their initial illness. Symptoms can include fatigue, difficulty concentrating, and psychological issues such as anxiety and depression, which can severely impact daily life and overall well-being.
The mental health implications of long COVID are particularly alarming. A study analyzing data from over 236,000 COVID-19 patients found that 34% were diagnosed with a neurological or psychiatric disorder within six months of infection, with anxiety disorders being the most common at 17%. This highlights the urgent need for healthcare systems to prepare for the long-term mental health needs of COVID-19 survivors.
In response to these challenges, various governments and organizations have begun to implement strategies aimed at addressing the mental health crisis exacerbated by the pandemic. For instance, the Scottish Government has outlined a plan to support mental health recovery, emphasizing the importance of personalized care and the need to adapt approaches as new mental health needs arise. This plan aims to ensure that individuals receive the right support at the right time, recognizing that recovery is not a linear process.
Despite these efforts, significant gaps in mental health services remain. The pandemic has disrupted many essential health services, leaving many individuals without the care they need. The WHO has reported that mental health services were among the most disrupted during the pandemic, with many countries struggling to provide adequate support for those experiencing mental health issues.
Moreover, the stigma surrounding mental health has been challenged during this time, with more people openly discussing their struggles and seeking help. This cultural shift presents an opportunity to further destigmatize mental health issues and promote a supportive environment for those in need.
As we look to the future, it is clear that the mental health impacts of COVID-19 will be felt for years to come. The need for increased investment in mental health resources is critical, as many countries currently allocate only a small percentage of their health budgets to mental health services. The WHO has called for a global step-up in investment to ensure that mental health support is accessible to all, particularly in light of the chronic underfunding that has historically plagued mental health services.
In conclusion, while there is a growing recognition of the mental health challenges posed by the COVID-19 pandemic, the journey to recovery is ongoing. Continued efforts to provide support, address stigma, and invest in mental health resources will be essential in helping individuals and communities heal from the psychological impacts of this unprecedented global crisis. The long-term effects of both the virus and the pandemic's social consequences will require sustained attention and action from health systems worldwide.

Related articles

Improving Online Health Literacy at Morrison Library on Feb. 10

On February 10, Morrison Library will host an event aimed at enhancing online health literacy. Participants will learn strategies to effectively navigate health information online, which is crucial for making informed health decisions.

Stanford Study Reveals Mechanism Behind mRNA Vaccine Myocarditis

A Stanford Medicine study has identified how mRNA COVID-19 vaccines can lead to myocarditis in rare cases, particularly among young males. The research highlights the role of specific immune signals and suggests potential strategies to mitigate this risk.

Brain Activity and Food Preoccupation in Tirzepatide Users

Recent research has revealed insights into brain activity related to food preoccupation in individuals using tirzepatide, a medication for type 2 diabetes. A case study highlighted how this drug temporarily suppressed signals in the brain's reward center, potentially offering new avenues for treating eating disorders. However, the effects were not long-lasting, indicating the need for further research.

Telix Pharmaceuticals Updates on Precision Medicine Portfolio

Telix Pharmaceuticals has announced significant updates regarding its precision medicine portfolio, including positive results from a Phase 3 study of TLX591-CDx in China, and progress on NDA resubmissions for TLX101-CDx and TLX250-CDx in the US These developments are expected to enhance treatment options for prostate cancer and glioma patients.

Risks of AI Recommending Thalidomide to Pregnant Women

The use of AI models like ChatGPT for medical advice raises significant concerns, particularly regarding the recommendation of harmful drugs like thalidomide to pregnant women. Studies show that these models can be manipulated to suggest unsafe medications, highlighting the need for caution and human oversight in AI-generated health information.